Measles is a highly contagious airborne disease caused by a virus that infects the respiratory tract and then spreads throughout the body. It remains one of the most infectious diseases known to medicine: a single infected person can pass the virus to up to 18 other people. Before widespread vaccination, nearly every child caught measles before adolescence, and the disease still causes significant illness and death worldwide in areas with low vaccine coverage.
How Measles Spreads
The measles virus travels through the air when an infected person breathes, coughs, or sneezes. What makes it exceptionally dangerous is that the virus stays active and contagious in the air, or on surfaces, for up to two hours after the infected person has left the room. You can catch measles simply by walking into a space where someone with the virus was standing earlier. No direct contact is necessary.
This airborne persistence is why measles spreads so efficiently in schools, waiting rooms, airports, and other shared indoor spaces. An infected person is contagious starting about four days before the rash appears and continuing for about four days after, meaning they can spread the virus before they even know they’re sick.
Symptoms and Timeline
After exposure, there’s a quiet incubation period of about 11 to 12 days before symptoms show up. The illness then unfolds in a predictable sequence.
The first symptoms look a lot like a bad cold: high fever, cough, runny nose, and red, watery eyes. Two to three days into this phase, tiny white spots called Koplik spots may appear inside the mouth, usually on the inner lining of the cheeks. These small, grain-like dots are unique to measles and often help confirm the diagnosis before the rash arrives.
The characteristic rash appears three to five days after the initial symptoms. It typically starts on the face and hairline, then spreads downward across the body over the course of a few days. When the rash breaks out, fever can spike above 104°F. The rash itself usually lasts five to six days before fading in the same order it appeared, from top to bottom. Most people feel significantly better once the rash begins to clear.
Why Measles Is More Dangerous Than It Looks
Measles is sometimes dismissed as a routine childhood illness, but it carries real risks. The majority of measles-related deaths are not caused by the virus itself but by secondary infections that take hold while the immune system is weakened. Pneumonia is the most common serious complication and the leading cause of measles-related death in young children. Inflammation of the brain (encephalitis) is rarer but can cause permanent brain damage or death.
There is also a rare, devastating late complication that can appear years after the initial infection. Called subacute sclerosing panencephalitis, or SSPE, it’s a progressive brain disease that is always fatal. It most often strikes children who had measles before age two, and symptoms can surface anywhere from seven to ten years later.
Immune Amnesia: The Hidden Cost
One of the most striking discoveries about measles in recent years is that the virus doesn’t just make you sick for a couple of weeks. It can erase your immune system’s memory of past infections. Researchers have found that measles destroys the specific immune cells (B lymphocytes) your body had built up from previous illnesses or vaccinations. Studies in unvaccinated children and in primates have measured a loss of up to 70% of the existing antibody repertoire after measles infection, though this varies considerably from person to person.
In practical terms, this means that after recovering from measles, your body may “forget” how to fight off diseases it had already learned to handle, whether through prior infection or vaccination. This immune amnesia leaves a person more vulnerable to other infections for months or potentially longer. It’s a major reason why spikes in other infectious diseases often follow measles outbreaks in a community.
Vaccination and Protection
The measles vaccine, typically given as part of the MMR (measles, mumps, rubella) combination, is the single most effective tool against the disease. A single dose is about 93% effective at preventing measles. The second dose, usually given a few years later, pushes protection to roughly 97%. That second dose isn’t a booster in the traditional sense. It catches the small percentage of people whose immune systems didn’t respond fully to the first shot.
Most countries recommend the first dose around 12 months of age and the second dose between ages four and six, though the exact schedule varies. Children under 12 months are typically protected by antibodies passed from their mother during pregnancy, assuming the mother was vaccinated or had measles herself. This borrowed immunity fades over the first year of life, which is why vaccination is timed for around the first birthday.
Treatment Options
There is no antiviral drug that targets the measles virus directly. Treatment focuses on managing symptoms, staying hydrated, and watching for complications. Fever reducers can help with comfort, and rest is essential.
Vitamin A supplementation plays a specific role. Both the World Health Organization and the American Academy of Pediatrics recommend vitamin A for children with measles because measles depletes the body’s vitamin A stores, and low vitamin A levels are associated with more severe illness. The evidence for vitamin A’s benefit is strongest in children under two. It doesn’t cure measles, but it can reduce the severity of complications and lower the risk of death, particularly in populations where vitamin A deficiency is already common.
Who Is Most at Risk
Measles can infect anyone who isn’t immune, but the consequences are most severe in certain groups. Children under five and adults over 20 tend to have the highest rates of complications. Pregnant women who contract measles face increased risks of premature birth and low birth weight. People with weakened immune systems, whether from medical conditions or treatments like chemotherapy, are especially vulnerable because they may not be able to receive the vaccine and are more likely to develop severe disease.
Malnourished children, particularly those with vitamin A deficiency, face the highest death rates from measles globally. This is why the disease remains a leading killer of young children in low-income countries where vaccine access is limited, even though it has been nearly eliminated in regions with strong immunization programs.